Loading...

SOHO 2026 Annual Meeting

This website and third-party tools we use rely on cookies for the best user experience. By selecting "I agree", you agree to cookie usage as described in our Privacy Policy.

1,267 posters, 47 videos, 13 topics, 4 sessions, 853 authors

ePostersLive by SciGen Technologies S.A. All rights reserved.

SOHO 2026 Annual Meeting

September 9 - 12, 2026 | George R. Brown Convention Center, Houston, Texas

Home Posters by Code Posters by Title Authors Topics Sessions Videos Previous meetings

Posters by Session

Select Session

Thumbnail for Socioeconomic and Geographic Disparities in Survival Outcomes Among Patients with Chronic Myelomonocytic Leukemia: A SEER-Based Analysis

MPN - 1641

Socioeconomic and Geographic Disparities in Survival Outcomes Among Patients with Chronic Myelomonocytic Leukemia: A SEER-Based Analysis

Mishaal Munir

Poster Presenter: Mishaal Munir

Thumbnail for KIT D816V-Selective Tyrosine Kinase Inhibitors for the Treatment of Advanced Systemic Mastocytosis: A Systematic Review and Meta-Analysis of Efficacy and Safety Outcomes

MPN - 1664

KIT D816V-Selective Tyrosine Kinase Inhibitors for the Treatment of Advanced Systemic Mastocytosis: A Systematic Review and Meta-Analysis of Efficacy and Safety Outcomes

Abdullah Ali

Poster Presenter: Abdullah Ali

Previous 1...129 130 131 132 133 134 135...141 Next

Copyright © 2015-2026, ePostersLive® SciGen is a registered trademark of SciGen Technologies S.A. Patent pending.

Thumbnail for Hypocellular Bone Marrow as an Independent Adverse Prognostic Feature in Primary Myelofibrosis: A Real-World Analysis of 241 Patients

MPN - 1673

Hypocellular Bone Marrow as an Independent Adverse Prognostic Feature in Primary Myelofibrosis: A Real-World Analysis of 241 Patients

Elmir Guluyev

Poster Presenter: Elmir Guluyev

Thumbnail for Luspatercept for Anemia in Myelofibrosis: A Systematic Evidence Synthesis and Random-Effects Meta-Analysis

MPN - 1675

Luspatercept for Anemia in Myelofibrosis: A Systematic Evidence Synthesis and Random-Effects Meta-Analysis

Arafat Shabbir

Poster Presenter: Arafat Shabbir

Thumbnail for Impact of GLP-1 Agonists on Clinical Outcomes in Patients With Essential Thrombocythemia: A Propensity-Matched Analysis

MPN - 1689

Impact of GLP-1 Agonists on Clinical Outcomes in Patients With Essential Thrombocythemia: A Propensity-Matched Analysis

Nneoma Ubah

Poster Presenter: Nneoma Ubah

Thumbnail for Ropeginterferon Alfa-2b vs Hydroxyurea in Polycythemia Vera: A Propensity Score-Matched Real-World Analysis of Thrombotic Events and Phlebotomy Burden

MPN - 1691

Ropeginterferon Alfa-2b vs Hydroxyurea in Polycythemia Vera: A Propensity Score-Matched Real-World Analysis of Thrombotic Events and Phlebotomy Burden

Vedant Shah

Poster Presenter: Vedant Shah

Thumbnail for Projected Healthcare Resource Use and Budget Impact of Once-Daily Extended-Release vs Twice-Daily Immediate-Release Ruxolitinib in Myelofibrosis

MPN - 204

Projected Healthcare Resource Use and Budget Impact of Once-Daily Extended-Release vs Twice-Daily Immediate-Release Ruxolitinib in Myelofibrosis

Sumit Verma

Poster Presenter: Sumit Verma

Thumbnail for Epigenetic Mutations as Markers of Clonal Evolution and Potential Guides for Therapy Selection in Ph-Negative Myeloproliferative Neoplasms

MPN - 234

Epigenetic Mutations as Markers of Clonal Evolution and Potential Guides for Therapy Selection in Ph-Negative Myeloproliferative Neoplasms

Anna Kirienko

Poster Presenter: Anna Kirienko

Thumbnail for Selinexor Alone and in Combination With JAK Inhibitors Suppresses Pro-Inflammatory Cytokine Secretion From Primary Myelofibrosis Cells Ex Vivo

MPN - 237

Selinexor Alone and in Combination With JAK Inhibitors Suppresses Pro-Inflammatory Cytokine Secretion From Primary Myelofibrosis Cells Ex Vivo

Trinayan Kashyap

Poster Presenter: Trinayan Kashyap

ePosters in

Topics Sessions

Acute Lymphoblastic Leukemia (ALL)(71)Acute Myeloid Leukemia (AML)(230)Aggressive B-Cell Lymphoma (ABCL)(114)Cellular Therapy (CT)(128)Chronic Lymphocytic Leukemia (CLL)(110)Chronic Myeloid Leukemia (CML)(55)Hodgkin Lymphoma (HL)(54)Indolent B-Cell Lymphoma (IBCL)(47)Mantle Cell Lymphoma (MCL)(23)Multiple Myeloma (MM)(234)

Previous 1 2 Next

Sponsors